Clinical trial
Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
NCT00449007 · New York State Psychiatric Institute, Other · Terminated
Key facts
| NCT number | NCT00449007 |
|---|---|
| Title | Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism |
| Official title | A Randomized Controlled Study Comparing Fluoxetine With Bupropion for Impulsivity and Suicidality in Patients With Major Depressive Disorder and Comorbid Alcoholism (Abuse or Dependence) |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Alcoholism, Suicidal Behavior |
| Intervention type | Drug |
| Interventions | fluoxetine, bupropion |
| Enrollment | 5 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Mar 19, 2007 |
| Last update posted | Aug 4, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: